Know Rare’s Post

This week on #BioTechNation: John Scarlett, MD, CEO of Geron Corporation, joins me to discuss Imetelstat, a potential game-changer for MDS patients. No more transfusions? It's possible after a 30-year R&D journey. Listen here or wherever you listen to podcasts: https://lnkd.in/gmB9DXTs #HealthcareInnovation #MedicalBreakthrough

As someone from Europe myself, I found it interesting to hear more about "Why is Europe a Drug Discovery Epicentre?", the latest podcast from Drug Discovery World. Below are few numbers and facts I found worth highlighting from the podcast, focusing on Europe with a closer look at Basel, Switzerland. 🌍 𝑬𝑼𝑹𝑶𝑷𝑬: ➡𝗕𝗼𝗼𝗺𝗶𝗻𝗴 𝗺𝗮𝗿𝗸𝗲𝘁: Market valued at $14.8 billion in 2020, growing 8.3% annually until 2030 (attributed to specialty meds, lifestyle diseases, population growth) ➡𝗕𝗶𝗴 𝗽𝗵𝗮𝗿𝗺𝗮 𝗱𝗿𝗶𝘃𝗲𝘀 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: Players like AstraZeneca, Bayer, Novartis, Pfizer fuel sector growth and advancements. ➡𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗵𝘂𝗯𝘀: France, Germany, UK lead with hubs. Swiss and UK see rapid growth: 63% of new biotechs between 2018-2020. ➡𝗠𝗮𝗿𝗸𝗲𝘁 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝗰𝗲: Europe accounts for 20% of global pharma market. UK remains strong despite Brexit (record high investments in 2021). ➡𝗦𝘄𝗶𝘀𝘀 𝘀𝘂𝗰𝗰𝗲𝘀𝘀: Swiss biotech thriving due to heavy R&D and global collaborations, and key role in COVID-19 treatments. ➡𝗚𝗲𝗿𝗺𝗮𝗻 𝗿𝗶𝘀𝗲: the country’s biotech profile has risen leading to record fundraising in 2020 with advancements in targeted protein degradation, cell & gene therapies. ➡𝗚𝗹𝗼𝗯𝗮𝗹 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: with strong research and development networks. 🌍𝑩𝑨𝑺𝑬𝑳 (𝐒𝐰𝐢𝐭𝐳𝐞𝐫𝐥𝐚𝐧𝐝) ➡𝗧𝗮𝗹𝗲𝗻𝘁 𝗽𝗼𝗼𝗹: robust talent pool in the life sciences, with 31,000 professionals. World-class academic institutions attract skilled candidates globally. ➡𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗰𝗹𝘂𝘀𝘁𝗲𝗿: home to pharmaceutical giants like Roche and Novartis. ➡𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗲𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺: due to Switzerland's stability, favorable tax laws, and business-friendly environment. The country actively promotes immigration and supports research collaborations. ➡𝗠𝘂𝗹𝘁𝗶𝗰𝘂𝗹𝘁𝘂𝗿𝗮𝗹 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁: Basel's location at the crossroads of three countries creates a multicultural workforce, with 47% speaking a second language encourages global collaboration in drug discovery. ➡𝗔𝗰𝗮𝗱𝗲𝗺𝗶𝗰 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀: 14 universities within an hour's drive facilitates interdisciplinary projects. Collaborations between academic institutions and industry (i.e. Neuroscience Network Basel) drive scientific breakthroughs. ➡𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀-𝗳𝗿𝗶𝗲𝗻𝗱𝗹𝘆 𝗽𝗼𝗹𝗶𝗰𝗶𝗲𝘀: with liberal labor laws, capital gains tax exemption, and financial support. Venture capitalists and technology parks further aid innovative ventures. ➡𝗥𝗮𝗽𝗶𝗱 𝗴𝗿𝗼𝘄𝘁𝗵: 9.3% annual rate from 2010 to 2020. 205 patent applications per million inhabitants submitted in 2018, ranking second only to Boston. ➡𝗛𝗶𝗴𝗵 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝘃𝗶𝘁𝘆: generated $526 per hour worked in 2020 (surpassing the San Francisco Bay area's $280).

I love listening to "The Weekly" each week! It keeps me updated on all things biopharma. Listen to this week's episode as Heather McKenzie, Greg Slabodkin and Tyler Patchen at BioSpace fill you in on what you need to know. #podcast #biopharma #biospace

If you have a rare cancer diagnosis and are interested in pursuing the possibility of a clinical trial, sometimes it can be hard to know where to start, or even find out more about what a clinical trial is. Cancer Research UK (CRUK) have produced this lovely podcast that talks about clinical trials and personalised medicine and what means to be a part of it. If this is something you are thinking about or are interested in, please have a listen here: The world of clinical trials - podcast https://bit.ly/3SeuVc7 If you have a rare cancer diagnosis and would like to find out more about clinical trials you may be suitable for, RareCan may be able to help you connect with researchers. #clinicaltrials #pharma #cancerresearch

https://lnkd.in/g4Db8zwV MedWaves microwave ablation is FDA cleared for: • Palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body. • Coagulation and ablation of tissue in bone during surgical procedures, including palliation of pain associated with metastatic lesions involving bone in patients who have failed or are not candidates for standard therapy. MedWaves microwave ablation system is effective in osteoblastic and osteolytic lesion. Bone metastases are classified as osteolytic (bone resorbing) or osteoblastic (bone forming). The processes of bone resorption and bone formation are normally coupled. In a disease state, such as cancer, this coupling is distorted toward either the osteolytic or osteoblastic phenotype.

Clinical trials are the gateways to a cancer-free world. Learn how clinical research leads to groundbreaking new treatments on our latest Cancer-Free World Podcast.

Everything You Never Knew About Ligaments | Podcast Ep. 269 Ligaments are some of the most important structures in our bodies. Discover everything you never knew about these incredibly important connective tissue bands on today's episode. Episode Highlights- Ligament Injury and Healing: A Review of Current Clinical Diagnostics and Therapeutics - https://bit.ly/3NMMHlr

A passion project of mine: I wanted to create a podcast featuring advanced practitioners where we discuss all things leukemia. In this episode, my guest speaker is Sami Salvatora where we talk about revuminib. Cheers!

Dr. Chris Beck interviews Interventional Radiologist Dr. Josh Kuban about his liver tumor ablation practice at MD Anderson Cancer Center, including how it's evolved over time with newer technologies. They also discuss patient workup for liver tumors, treatment with microwave ablation, and post-procedure follow up. Full Episode: https://ow.ly/4VMm50QmLIb #LiverCancer #TumorAblation #Hepatology #MicrowaveAblation #InterventionalRadiology

Understanding the concept of thrombophilia, including its various traits and their roles in thrombotic events is crucial. In part one in this podcast series, two hematology experts share their knowledge on the differences between acquired or inherited thrombophilia and discuss which specific patients can benefit from screening to prevent overtreatment or undertreatment. Don't forget that part two is coming soon! Watch it here: https://ow.ly/q6vt50R908s #Meded #thrombophilia